Literature DB >> 11157552

Drug treatment of multiple sclerosis. Clinical review was unsystematic.

R Milne, A Clegg, J Bryant.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11157552      PMCID： PMC1119535     

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

Review 1.  Disease-modifying drugs for multiple sclerosis: a rapid and systematic review.

Authors:  A Clegg; J Bryant; R Milne
Journal:  Health Technol Assess       Date:  2000       Impact factor: 4.014

Review 2.  Drug treatment of multiple sclerosis.

Authors:  C H Polman; B M Uitdehaag
Journal:  BMJ       Date:  2000 Aug 19-26

3.  Cost utility of drugs for multiple sclerosis. Systematic review places study in contrast.

Authors:  J Bryant; A Clegg; R Milne
Journal:  BMJ       Date:  2000-05-27

4.  Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Gadolinium MRI Meta-analysis Group.

Authors:  L Kappos; D Moeri; E W Radue; A Schoetzau; K Schweikert; F Barkhof; D Miller; C R Guttmann; H L Weiner; C Gasperini; M Filippi
Journal:  Lancet       Date:  1999-03-20       Impact factor: 79.321
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.